ClinicalTrials.Veeva

Menu

Hyperbaric Oxygen Therapy for Peripheral Neuropathy Due to Paclitaxel Analogs

G

Guangdong Provincial People's Hospital (Guangdong Provincial Academy of Medical Sciences)

Status

Not yet enrolling

Conditions

Breast Cancers

Treatments

Behavioral: routine care
Device: hyperbaric oxygenation treatment

Study type

Interventional

Funder types

Other

Identifiers

NCT06819501
KY2024-1015-04

Details and patient eligibility

About

The goal of this study was to explore the safety and efficacy of hyperbaric oxygen in the treatment of peripheral neuropathy due to paclitaxel analogues

Enrollment

226 estimated patients

Sex

Female

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patients with newly diagnosed breast cancer by pathology
  2. Age 18-60 years
  3. ECOG 0-2
  4. CIPN patients with NCI-CTCAE grade 1 or higher after treatment with paclitaxel-based drugs

Exclusion criteria

  1. Patients with contraindications to hyperbaric oxygen i. Untreated pneumothorax. ii. concomitant administration of disulfiram. iii. concomitant administration of antineoplastic drugs such as bleomycin, cisplatin, adriamycin. iv. premature and/or low body mass newborns.

    iv. Premature and/or low body mass neonates.

  2. Other cancers

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

226 participants in 2 patient groups

Hyperbaric Oxygen group
Experimental group
Description:
Administration of 100% oxygen at a pressure of 2.0ATA once daily for 60-90 minutes for a total of 30-40 times and administration of pressurised ice gloves 30 minutes before, during and 30 minutes after the administration of paclitaxel-based chemotherapeutic agents.
Treatment:
Device: hyperbaric oxygenation treatment
Behavioral: routine care
Control group
Active Comparator group
Description:
Administration of pressurised ice gloves 30 minutes before, during, and 30 minutes after administering paclitaxel chemotherapy drugs.
Treatment:
Behavioral: routine care

Trial contacts and locations

1

Loading...

Central trial contact

Kun wang, Professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems